Fourth COVID-19 Vaccine Dose- mRNA1273

Clinical trial NCT05230953 · UNKNOWN

Trial details

NCT number: NCT05230953
Sponsor: Sheba Medical Center
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 Pandemic

Start date: 2022-01-05
Primary completion: 2024-07-04
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.